Global Anticoagulants Industry
9. PRODUCT INTRODUCTIONS/APPROVALS IN RECENT PAST- A PERSPECTIVE
BUILDER II-60
GSK Receives EU Approval for Arixtra® II-60
Pradaxa Receives FDA Approval II-60
Canyon Pharmaceuticals Introduces Iprivask II-60 Teva Receives FDA's Tentative Approval for Argatroban II-60 TrimGen Receives FDA 510(k) Approval for Marketing eQ-PCR™ LC Warfarin Genotyping Kit II-61 Lundbeck Launches ATryn® Commercially in the US II-61 The Medicines Co Receives European Approval for Angiox ( Bivalirudin) II-61 10. RECENT INDUSTRY ACTIVITY II-62 FDA Issues Complete Response Letter for Eliquis's New Drug Application II-62 FDA Issues Complete Response Letter to Rivaroxaban's (Xarelto) NDA for ACS II-62 US FDA Extends Date for Eliquis' New Drug Application II-62 Pradaxa® Receives NICE Recommendation II-62 BioInvent and ThromboGenics Discontinue Development of TB-402 II-62 Watson Receives Stay Order on Preliminary Injunction II-63 FDA Assigns Priority Review for Xarelto Supplemental NDA II-63 Portola Pharmaceuticals Re-Acquires Rights to Betrixaban II-63 FDA Accepts New Drug Application for ELIQUIS® II-63 Astellas Pharma Halts Development of Anticoagulant II-63 Sanofi-Aventis Changes Name to Sanofi II-63 11. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER II-64 Boehringer Ingelheim Expands Manufacturing Capacity at Ingelheim II-64 Sagent Pharmaceuticals Secures FDA Approval for Heparin Sodium Injection II-64 Biomet Acquires Cytosol Laboratories II-64 Portola Inks $470 M Agreement with Merck for Phase II Anticoagulant II-64 Catalent Pharma Inks Strategic Alliance Deal with Endotis Pharma II-65 Nuvelo and ARCA biopharma Merge II-65 12. FOCUS ON SELECT GLOBAL PLAYERS II-66 Bayer Healthcare AG ( Germany) II-66 Boehringer Ingelheim ( Germany) II-66 Bristol-Myers Squibb Company ( USA) II-66 Eisai Inc. ( USA) II-67 GlaxoSmithKline plc (UK) II-67 LEO Pharmaceutical Products ( Denmark) II-67 Mitsubishi Tanabe Pharma Corporation ( Japan) II-68 Pfizer Inc. ( USA) II-68 Sanofi ( France) II-68 Teva Pharmaceutical Industries Ltd ( Israel) II-69 Teva Pharmaceuticals USA ( USA) II-69Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
